• Recall is isolated to powder formulas, including Similac®, Alimentum ® and EleCare®, manufactured at the Sturgis, Mich., plant
  • Recall does not include any metabolic deficiency nutrition formulas
  • No Abbott liquid formulas or other Abbott nutrition powders and brands are impacted
  • Parents or customers with impacted product should visit similacrecall.com or call +1-800-986-8540

ABBOTT PARK, Ill., Feb. 17, 2022 /PRNewswire/ — Abbott (NYSE: ABT) is initiating a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare manufactured in Sturgis, Mich., one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas.

Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.

Additionally, as part of Abbott’s quality processes, we conduct routine testing for Cronobacter sakazakii and other pathogens in our manufacturing facilities. During testing in our Sturgis, Mich., facility, we found evidence of Cronobacter sakazakii in the plant in non-product contact areas. We found no evidence of Salmonella Newport. This investigation is ongoing.

Importantly, no distributed product has tested positive for the presence of either of these bacteria, and we continue to test. Abbott conducts extensive quality checks on each completed batch of infant formula, including microbiological analysis prior to release. All finished products are tested for Cronobacter sakazakii, Salmonella Newport and other pathogens and they must test negative before any product is released. Additionally, retained samples related to the three complaints for Cronobacter sakazakii tested negative for Cronobacter sakazakii. And the retained sample related to the complaint for Salmonella Newport tested negative for Salmonella Newport.

While Abbott’s testing of finished product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later. No Abbott liquid formulas, powder formulas, or nutrition products from other facilities are impacted by the recall.

Cronobacter sakazakii is commonly found in the environment and a variety of areas in the home. It can cause fever, poor feeding, excessive crying or low energy as well as other serious symptoms. It’s important to follow the instructions for proper preparation, handling and storage of powder formulas.

Read the full article >

Atracare Health Pediatrician Dr. Lewis is recommending that patients on one of the recalled Similac formulas switch to the equivalent Enfamil formulas as follows:
  • Similac Advance/Pro-Advance: Switch to Enfamil NeuroPro
  • Similac Sensitive: Switch to Enfamil Sensitive
  • Similac Total Comfort: Switch to Enfamil Gentlease
  • Similac Alimentum: Switch to Nutramigen

Contact Atracare Health with questions or inquiries related to this recall.

0 New comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News and Clinic Information

We are your partner in health. Stay up to date with latest news and information.

Atracare & The Medical Society of Delaware: Fighting for Prior Authorization Reform

Have you ever been frustrated waiting for an insurance company to approve a procedure, surgery, or even a prescription? You’re not alone — and Atracare is taking an active role in helping change that.

In a recent Public Service Announcement, Atracare’s own Will Albanese highlights an important patient advocacy effort happening right now in Delaware. The Medical Society of Delaware is working to reform the prior authorization process, which often delays care while insurance companies decide whether to approve medically necessary treatments.

These unnecessary delays can stretch from days to weeks, creating unnecessary stress and sometimes preventing timely care altogether. That’s why new legislation, supported by the Medical Society of Delaware, is so important. The proposed bill would require insurance companies to respond to prior authorization requests within hours, not days, helping patients get the care and medications they need without frustrating hold-ups.

Read More

Federal cuts expected to hit Sussex healthcare hard

Some local healthcare leaders say cuts in President Donald Trump’s “Big, Beautiful Bill” could hit especially hard in Sussex County, where a physician shortage and a rapidly growing senior population already make it difficult for many to get care.

Read More

Meet Shamaya Hagan, LMSW — Now Seeing Clients at Atracare Mental Health

Atracare is excited to introduce the newest addition to our growing Mental Health team: Shamaya Hagan, LMSW. A Delaware native from Seaford, Shamaya brings both professional expertise and a deeply personal approach to her work, helping clients navigate some of life’s most difficult seasons.

Read More